We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
-20.16%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$25.2M
(+2.1%)
Cap. Flow
+$287M
Cap. Flow
% of AUM
23.51%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,483
New
378
Increased
381
Reduced
313
Closed
382
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Asana
ASAN
|
+$8.41M |
| 2 |
Marvell Technology
MRVL
|
+$8.25M |
| 3 |
GlobalFoundries
GFS
|
+$7.98M |
| 4 |
Netflix
NFLX
|
+$7.87M |
| 5 |
Zebra Technologies
ZBRA
|
+$7.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$6.39M |
| 2 |
Trade Desk
TTD
|
+$6.28M |
| 3 |
Xylem
XYL
|
+$6.22M |
| 4 |
Gilead Sciences
GILD
|
+$6.21M |
| 5 |
Under Armour
UAA
|
+$6.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.57% |
| 2 | Healthcare | 15.01% |
| 3 | Industrials | 12.49% |
| 4 | Financials | 12.17% |
| 5 | Consumer Discretionary | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Northwest Bancshares
NWBI
$2.3B
| $950K | 0.08% |
74,217
+1,648
| +2% | +$21K |
|
|
ISEE
402
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $948K | 0.08% |
+98,568
| New | +$1.24M |
|
403
Janus International
JBI
$700M
| $938K | 0.08% |
103,931
+16,439
| +19% | +$160K |
|
404
Globus Medical
GMED
$10.7B
| $936K | 0.08% |
16,666
+7,260
| +77% | +$477K |
|
405
Bankunited
BKU
$3.37B
| $935K | 0.08% |
26,297
-5,152
| -16% | -$204K |
|
406
Plains GP Holdings
PAGP
$5.21B
| $931K | 0.08% |
90,252
-18,973
| -17% | -$218K |
|
407
Williams-Sonoma
WSM
$26.9B
| $929K | 0.08% |
+16,754
| New | +$1.08M |
|
408
ZipRecruiter
ZIP
$321M
| $926K | 0.08% |
62,512
+6,918
| +12% | +$137K |
|
|
CMA
409
DELISTED
Comerica
CMA
| $924K | 0.08% |
+12,593
| New | +$1.02M |
|
410
Jack Henry & Associates
JKHY
$10.9B
| $924K | 0.08% |
5,132
-2,573
| -33% | -$482K |
|
411
Monro
MNRO
$383M
| $921K | 0.08% |
21,484
-3,547
| -14% | -$159K |
|
412
Renasant Corp
RNST
$3.98B
| $917K | 0.08% |
31,828
+4,108
| +15% | +$126K |
|
413
Veeco
VECO
$3.05B
| $915K | 0.08% |
47,148
-1,614
| -3% | -$35.8K |
|
|
DENN
414
DELISTED
Denny's
DENN
| $913K | 0.07% |
105,214
+52,183
| +98% | +$576K |
|
415
PBF Energy
PBF
$8.57B
| $913K | 0.07% |
31,467
-2,925
| -9% | -$91.5K |
|
416
Ardmore Shipping
ASC
$710M
| $908K | 0.07% |
+130,319
| New | +$872K |
|
417
Ring Energy
REI
$315M
| $904K | 0.07% |
339,974
+111,239
| +49% | +$460K |
|
418
Coeur Mining
CDE
$15.4B
| $902K | 0.07% |
296,645
-178,354
| -38% | -$701K |
|
419
Graham Holdings Company
GHC
$5.1B
| $900K | 0.07% |
1,587
-2
| -0.1% | -$1.19K |
|
|
RTLR
420
DELISTED
Rattler Midstream LP Common Units
RTLR
| $899K | 0.07% |
65,868
+41,444
| +170% | +$612K |
|
421
Glacier Bancorp
GBCI
$6.42B
| $897K | 0.07% |
18,926
+432
| +2% | +$20.4K |
|
422
F5
FFIV
$22.9B
| $893K | 0.07% |
5,836
+2,317
| +66% | +$403K |
|
423
Codexis
CDXS
$151M
| $883K | 0.07% |
+84,415
| New | +$1.06M |
|
|
VERV
424
DELISTED
Verve Therapeutics
VERV
| $883K | 0.07% |
+57,777
| New | +$895K |
|
425
Cytokinetics
CYTK
$10.5B
| $878K | 0.07% |
22,347
-7,586
| -25% | -$305K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
WIC
OFS
LOAME
Occudo Quantitative Strategies's Q2 2022 Portfolio in Review
As of Q2 2022, Occudo Quantitative Strategies held 1,483 positions worth $1.22B, up 2.1% from $1.19B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
Occudo Quantitative Strategies deployed $287M of net new capital in Q2 2022, opening 378 new positions and adding to 381 existing holdings. Its largest new stake was Marvell Technology: 145,519 shares worth $6.33M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $5.12M trimmed.
- Occudo Quantitative Strategies's largest Q2 2022 buy was Marvell Technology: 145,519 shares worth $6.33M.
- Occudo Quantitative Strategies added most to Asana in Q2 2022, an estimated $8.41M increase.
- Occudo Quantitative Strategies's biggest Q2 2022 reduction was Sherwin-Williams, cutting an estimated $5.12M.
- Occudo Quantitative Strategies fully exited 3M in Q2 2022, selling an estimated $6.39M.
- Occudo Quantitative Strategies's ten largest holdings make up 5.2% of its $1.22B portfolio in Q2 2022.
- Occudo Quantitative Strategies opened 378 new positions and closed 382 in Q2 2022.
- Occudo Quantitative Strategies's portfolio value rose 2.1% quarter-over-quarter to $1.22B.
Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.